| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 2.2 | 2.0 | 4.8 | 6.0 | 5.4 | 1,834.5 | 2.1 | −99.9% | |
| Selling, general & administrative | 2.4 | 10.8 | 7.3 | 8.5 | 8.7 | 6,257.5 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 4.6 | 12.8 | 12.1 | 14.6 | 14.1 | 8.1 | 7.7 | −5.2% | |
| Operating income | (4.6) | (12.8) | (12.1) | (14.6) | (14.1) | (8.1) | (7.7) | +5.2% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | +29.8% | |
| Other income / expense | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | — | — | |
| Pre-tax income | (4.6) | (12.7) | (12.1) | (14.6) | (14.1) | (8.0) | (7.5) | +5.8% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (4.6) | (12.7) | (12.1) | (14.6) | (14.1) | (8.0) | (7.5) | +5.8% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (9.28) | (24.96) | (22.36) | (23.01) | (17.59) | (5.32) | (3.55) | +33.2% | |
| EPS, diluted (per share) | (9.28) | (24.96) | (22.36) | (23.01) | (17.59) | (5.32) | (3.55) | +33.2% | |
| EBITDA | 0.0 | (12.7) | (12.1) | (14.6) | 0.0 | (8.0) | (7.6) | +4.2% | |
| Depreciation & amortization | 4.6 | 0.0 | 0.0 | 0.0 | 14.1 | 0.0 | — | — | |
| Weighted average shares (shares) | 495,800 | 510,800 | 540,800 | 633,600 | 851,550 | 1,499,000 | — | — | |
| Weighted average diluted shares (shares) | 495,800 | 510,800 | 540,800 | 633,600 | 851,550 | 1,499,000 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
